Assessing the use of prescription drugs and dietary supplements in obese respondents in the National Health and Nutrition Examination Survey
Open Access
- 3 June 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (6) , e0269241
Abstract
Introduction: Obesity is a common disease and a known risk factor for many other conditions such as hypertension, type 2 diabetes, and cancer. Treatment options for obesity include lifestyle changes, pharmacotherapy, and surgical interventions such as bariatric surgery. In this study, we examine the use of prescription drugs and dietary supplements by the individuals with obesity. Methods: We conducted a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2003–2018. We used multivariate logistic regression to analyze the correlations of demographics and obesity status with the use of prescription drugs and dietary supplement use. We also built machine learning models to classify prescription drug and dietary supplement use using demographic data and obesity status. Results: Individuals with obesity are more likely to take cardiovascular agents (OR = 2.095, 95% CI 1.989–2.207) and metabolic agents (OR = 1.658, 95% CI 1.573–1.748) than individuals without obesity. Gender, age, race, poverty income ratio, and insurance status are significantly correlated with dietary supplement use. The best performing model for classifying prescription drug use had the accuracy of 74.3% and the AUROC of 0.82. The best performing model for classifying dietary supplement use had the accuracy of 65.3% and the AUROC of 0.71. Conclusions: This study can inform clinical practice and patient education of the use of prescription drugs and dietary supplements and their correlation with obesity.Keywords
All Related Versions
Funding Information
- National Institute on Aging (R21AG061431)
- National Center for Advancing Translational Sciences (UL1TR001427)
- National Center for Complementary and Integrative Health (R01AT009457)
This publication has 51 references indexed in Scilit:
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index CategoriesJAMA, 2013
- Rise and fall of anti-obesity drugsWorld Journal of Diabetes, 2011
- Depression and obesity: A meta-analysis of community-based studiesPsychiatry Research, 2010
- Normal Body Mass Index Rather than Obesity Predicts Greater Mortality in Elderly People: The Jerusalem Longitudinal StudyJournal of the American Geriatrics Society, 2009
- Use of Dietary Supplements for Weight Loss in the United States: Results of a National SurveyObesity, 2008
- Explaining Racial and Ethnic Disparities in Health CareMedical Care, 2006
- Excess Deaths Associated With Underweight, Overweight, and ObesityJAMA, 2005
- Data mining in bioinformatics using WekaBioinformatics, 2004
- Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathyInternational Journal of Obesity, 1999
- Brain Serotonin, Carbohydrate‐Craving, Obesity and DepressionObesity Research, 1995